CD8A and breast cancer: To determine if the suppression of anti-tumor CD8+ T immune cells was linked to changes in antigen presentation, we assessed the expression of histocompatibility complex (MHC) class I (RT1.A1 and RT1.EC2) and class II genes (RT1.Bb and RT1.Da) in the mammary tumors of the offspring.